New clinical evidence supporting Asserachrom HPIA-IgG in HIT diagnosis
A prospective multicentre study recently published in the International Journal of Laboratory Hematology provides new clinical evidence supporting Asserachrom HPIA-IgG in patients with suspected heparin-induced thrombocytopenia.
Read more
New Practical Manual on Clinical cases in Thrombosis and Haemostasis
This 11th new book is dedicated to Clinical cases in Thrombosis and Haemostasis with a focus on complex clinical situations. This new issue deliberately adopts a clinically driven approach, composed entirely of real-life cases drawn from routine practice.
Read more
Join Stago at ISTH 2026: a unique Grand Palais experience
Meet us at ISTH 2026, from July 11 to 15, with a brand-new booth concept inspired by the iconic Parisian Grand Palais. This year, step into a unique environment blending scientific innovation and Parisian atmosphere, featuring a café setting and elegant gallery-inspired design. Discover our latest solutions in a fully digital experience, engage with hemostasis experts through dedicated sessions, and explore the future of hemostasis in a more interactive way than ever before.
Read more
Stago Accelerates Its Growth with ARCHIMED and La Caisse
Communication of April 29, 2026
For nearly eighty years, Stago has been developing solutions grounded in rigorous scientific standards, driven by a constant ambition: to support healthcare professionals and contribute to improved patient care.
As a leading global player in hemostasis, the company has built its identity on a culture of excellence, recognized expertise, and a long-term vision.
Today, Stago is entering a new phase in its history.
Read more
Stago webinar: Bleeding disorders of unknown cause - challenges in diagnosis and patient management
This webinar aims to provide clinicians, clinical pathologists, researchers, and laboratory professionals with practical guidance on accurately identifying patients with Bleeding disorders of unknown cause (BDUC) and effectively managing their bleeding risk.
Read more